Related Experiment Video
Updated: Feb 22, 2026
06:33
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
1.9K
The Bone Marrow Microenvironment in Health and Myeloid Malignancy
Marta Galán-Díez1, Álvaro Cuesta-Domínguez1, Stavroula Kousteni1
1Department of Physiology & Cellular Biophysics, College of Physicians & Surgeons, Columbia University, New York, New York 10032.
Cold Spring Harbor Perspectives in Medicine
|October 1, 2017
Summary
Hematopoietic stem cells (HSCs) interact with the bone marrow niche, influencing blood cell production and quiescence. Disruptions in this niche contribute to myeloid malignancies, highlighting its therapeutic potential.
Area of Science:
- Hematology
- Stem Cell Biology
- Cancer Biology
Background:
- Hematopoietic stem cells (HSCs) reside within the bone marrow (BM) microenvironment, or niche.
- This niche provides critical signals regulating HSC function, including blood cell production, lineage determination, and quiescence maintenance.
- Dysregulation of the BM niche is implicated in hematopoietic stem cell dysfunction and the development of myeloid malignancies.
Purpose of the Study:
- To review the impact of the BM niche on normal hematopoiesis.
- To explore the molecular signals governing HSC-niche interactions.
- To discuss how niche alterations contribute to myeloid malignancies.
Main Methods:
- Literature review of studies on HSC-niche interactions.
- Analysis of molecular mechanisms underlying niche regulation.
- Examination of genetic and environmental factors in malignant BM niches.
Main Results:
- The BM niche plays a crucial role in maintaining HSC homeostasis and normal blood cell development.
- Specific molecular signals mediate HSC-niche communication, influencing cell fate.
- Genetic alterations in stromal cells and a remodeled malignant niche promote aberrant HSC function and myeloid cancers.
Conclusions:
- The bone marrow niche is a dynamic regulator of both normal hematopoiesis and myeloid malignancies.
- Understanding the interplay between HSCs and their niche offers potential therapeutic targets for blood disorders.
- Modulating niche components may provide novel strategies for treating myelodysplastic syndromes and leukemia.
Related Concept Videos
02:17The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
01:15Differentiation of Common Myeloid Progenitor Cells
4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K
01:22Bone Marrow Sampling and Transplants
1.7K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.7K
01:01Regulation of Hematopoietic Stem Cells
4.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
01:27Disorders of Leukocytes
2.1K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.1K